We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock
INBX

Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

2 hedge funds and large institutions have $1.16M invested in Inhibrx, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 123 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 126 → 2 (-124)

100% less capital invested

Capital invested by funds: $1.34B → $1.16M (-$1.34B)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 123

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-124
Holders Change %
-98.41%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
123
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$250M
2
PA
Perceptive Advisors
New York
-$149M
3
BlackRock
BlackRock
New York
-$96.2M
4
RCM
RA Capital Management
Massachusetts
-$91.9M
5
State Street
State Street
Massachusetts
-$84.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
DekaBank Deutsche Girozentrale
1
DekaBank Deutsche Girozentrale
Germany
$928K – – –
Osaic Holdings
2
Osaic Holdings
Arizona
$228K -$18.5K -537 -7%
Viking Global Investors
3
Viking Global Investors
Connecticut
– -$250M -7,150,826 Closed
PA
4
Perceptive Advisors
New York
– -$149M -4,256,104 Closed
BlackRock
5
BlackRock
New York
– -$96.2M -2,751,705 Closed
RCM
6
RA Capital Management
Massachusetts
– -$91.9M -2,629,837 Closed
State Street
7
State Street
Massachusetts
– -$84.5M -2,417,584 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$65.1M -1,861,469 Closed
TCM
9
TCG Crossover Management
California
– -$61.2M -1,750,387 Closed
SI
10
Sofinnova Investments
California
– -$45.5M -1,302,645 Closed
Citadel Advisors
11
Citadel Advisors
Florida
– -$42.1M -1,204,252 Closed
AAM
12
Alpine Associates Management
Florida
– -$36.9M -1,054,475 Closed
ACH
13
ArrowMark Colorado Holdings
Colorado
– -$31.2M -891,220 Closed
Walleye Capital
14
Walleye Capital
New York
– -$28M -800,000 Closed
Bank of America
15
Bank of America
North Carolina
– -$25.9M -741,591 Closed
Geode Capital Management
16
Geode Capital Management
Massachusetts
– -$24.6M -704,825 Closed
TCM
17
Tang Capital Management
California
– -$24.5M -700,000 Closed
Morgan Stanley
18
Morgan Stanley
New York
– -$19.2M -549,469 Closed
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
– -$19M -542,971 Closed
MI
20
MMCAP International
Cayman Islands
– -$15.8M -451,433 Closed
UBS Group
21
UBS Group
Switzerland
– -$15.6M -445,197 Closed
SC
22
Slotnik Capital
Texas
– -$14.7M -419,778 Closed
Goldman Sachs
23
Goldman Sachs
New York
– -$13.2M -376,540 Closed
TAL
24
TIG Advisors LLC
New York
– -$11.7M -333,988 Closed
Citigroup
25
Citigroup
New York
– -$11.6M -331,302 Closed
1
2 3 4 5

INBX Hedge Fund Activity: Q2 2024 in Review

2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q2 2024, worth a combined $1.16M — down 100% from $1.34B a quarter earlier.

Sellers outnumbered buyers: 123 funds closed out of INBX and 0 opened new positions — a net loss of 123 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Viking Global Investors, exiting entirely with an estimated $250M sold.

  • 2 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q2 2024, down from 126 in Q1 2024.
  • Funds reported $1.16M of Inhibrx, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Inhibrx, Inc. Common Stock positions in Q2 2024 and 123 closed out, a net change of -123 holders.
  • The largest Inhibrx, Inc. Common Stock seller in Q2 2024 was Viking Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q2 2024.